Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

May 2014 Issue of The Ophthalmologist

Register to download

Register here to download any issue of The Ophthalmologist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Business & Profession Professional Development

A Touch of Thoughtfulness

| Mark Hillen

Certain patients don't get the treatment that they need. A little understanding and forward planning can solve the problem.

Subspecialties Glaucoma

Glaucoma’s Fifty Shades of Grey

| Mark Hillen

Actually, it's 1,000 shades – that’s what the human eye can discriminate in adapting to bright and dark condition. How does glaucoma affect this ability?

Business & Profession Professional Development

Valeant Stalks Allergan

| Mark Hillen

To shave $2.7 billion from costs there will be substantial cuts and job losses

Business & Profession Other

Don’t Disrespect Diamox

| Mark Hillen

Around since the 1950s, it has now been proven to improve visual outcomes in patients with idiopathic intracranial hypertension

Business & Profession Professional Development

Regrets, I’ve Had a Few…

| Mark Hillen

If you had your time again, would you go to medical school, and would you choose ophthalmology?

Subspecialties Cornea / Ocular Surface

Combatting Corneal Steepening

| Mark Hillen

A three-year study of progressive keratoconus has shown that corneal cross-linking is associated with sustained delay in disease progression.

Business & Profession Other

The Uniqueness of Uveal Melanoma

| Takami Sato , Carol Shields

Uveal and skin melanoma originate in the same type of cell, but are very different in terms of molecular mechanism, pathobiology, prognosis and therapeutic strategy. Here, the features of uveal melanoma are described and the latest therapeutic developments discussed.

Subspecialties Professional Development

Serving Patients who have Learning Disabilities

| Rachel Pilling

People with learning disabilities are ten times more likely to have serious sight problems than the general population and often fail to receive the same standard of care. Here’s how to avoid some of the pitfalls and some tips for a successful doctor-patient relationship.

Business & Profession Refractive

How to Reduce Higher-Order Aberrations

A new technology that measures subjective refraction based on point spread function targets generates better data, increases efficiency in the clinic and improves patient outcomes.

Business & Profession Cornea / Ocular Surface

Beaming for Better Cross Linking

| David Geffen, Paul Karpecki

Increasing the light intensity over the thinnest point of the cornea – the periphery –improves outcomes of corneal collagen cross-linking in keratectasia patients.

Subspecialties Retina

Benchmarking Stargardt Disease

| Mark Hillen

What does analysis of the last five years of the literature on Stargardt Disease tell us about the priorities of the field and the major contributors to it?

Subspecialties Cornea / Ocular Surface

PACK-CXL For All

| Farhad Hafezi

The concept of using photoactivated chromophores for corneal cross-linking (PACK-CXL) as a weapon against infectious keratitis is compelling. The evidence suggests that PACK-CXL could have a dramatic impact on a major cause of global blindness… but only if the expensive, bulky technology (and the requirement for a corneal surgeon in a sterile operating theater) can be overcome. One company may have the answer.

Subspecialties Cataract

A Brief History of IOL Materials

| Florian Kretz, Sibylle Scholtz, Gerd Auffarth

The development and use of intraocular lenses has been a major ophthalmic success story. Here, we describe some of the key contributions and the materials that revolutionized cataract treatment.

Subspecialties Professional Development

First Lady of the Gonin Medal

Sitting Down With Alice McPherson,founder of the Retina Research Foundation

Other issues of 2014